Dopamine versus dobutamine in very low birthweight infants: Endocrine effects

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 92, Issue 5, 2007, Pages

  Filippi, Luca ^a   Pezzati, Marco ^b   Poggi, Chiara ^a   Rossi, Sauro ^c   Cecchi, Alessandra ^a   Santoro, Cristina ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SAN GIOVANNI DI DIO HOSPITAL   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; DOPAMINE; GROWTH HORMONE; PROLACTIN; THYROTROPIN; THYROXINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFECT; ENDOCRINE FUNCTION; FEMALE; GROWTH HORMONE BLOOD LEVEL; HEART HEMODYNAMICS; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NEWBORN; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; VERY LOW BIRTH WEIGHT;

BLOOD PRESSURE; CARDIOTONIC AGENTS; DOBUTAMINE; DOPAMINE; FEMALE; HEART RATE; HUMAN GROWTH HORMONE; HUMANS; HYPOTENSION; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE, NEONATAL; MALE; PROLACTIN; PROSPECTIVE STUDIES; THYROTROPIN; THYROXINE; TREATMENT OUTCOME;

EID: 34548794721     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2006.098566     Document Type: Article

References (44)

1. Gill AB, Weindling AM. Randomised controlled trial of plasma protein fraction versus dopamine in hypotensive very low birthweight infants. Arch Dis Child 1993;69:284-7.
2. Cunningham S, Symon AG, Elton RA, et al. Intra-arterial blood pressure reference ranges, death and morbidity in very low birthweight infants during the first seven days of life. Early Hum Dev 1999;56:151-65.
3. Goldstein RF, Thompson RJ, Oehler JM, et al. Influence of acidosis, hypoxaemia, and hypotension on neurodevelopmental outcome in very low birth weight infants. Pediatrics 1995;95:238-43.
4. Miall-Allen VM, De Vries LS, Whitelaw AGL. Mean arterial blood pressure and neonatal cerebral lesions. Arch Dis Child 1987;62:1068-9.
5. Munro MJ, Walker AM, Barfield CP. Hypotensive extremely low birth weight infants have reduced cerebral blood flow. Pediatrics 2004;114:1591-6.
6. Lou HC, Skov H, Pedersen H. Low cerebral blood flow: a risk factor in the neonate. J Pediatr 1979;95:606-9.
7. Meek JH, Tyszczuk L, Elwell CE, et al. Low cerebral blood flow is a risk factor for severe intraventricular haemorrhage. Arch Dis Child Fetal Neonatal Ed 1999;81:F15-8.
8. So KW, Fok TF, Ng PC, et al. Randomised controlled trial of colloid or crystalloid in hypotensive preterm infants. Arch Dis Child 1997;76:F43-6.
9. Greenough A, Emery EF. Randomized trial comparing dopamine and dobutamine in preterm infants. Eur J Pediatr 1993;152:925-7.
10. Hentschel R, Hensel D, Brune T, et al. Impact on blood pressure and intestinal perfusion of dobutamine or dopamine in hypotensive preterm infants. Biol Neonate 1995;68:318-24.
11. Klarr JM, Faix RG, Pryce CJE, et al. Randomized, blind trial of dopamine versus dobutamine for treatment of hypotension in preterm infants with respiratory distress syndrome. J Pediatr 1994;125:117-22.
12. Roze JC, Tohier C, Maingueneau C, et al. Response to dobutamine and dopamine in the hypotensive very preterm infant. Arch Dis Child 1993;69:59-63.
13. Ruelas-Orozco G, Varga-Origel A. Assessment of therapy for arterial hypotension in critically ill preterm infants. Am J Perinatol 2000;17:95-9.
14. Subhedar NV, Shaw NJ. Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Database Syst Rev 2003;3:CD001242.
15. Filippi L, Cecchi A, Tronchin M, et al. Dopamine infusion and hypotiroxinemia in very low birth weight preterm infants. Eur J Pediatr 2004;163:7-13.
16. Filippi L, Pezzati M, Cecchi A, et al. Dopamine infusion and anterior pituitary gland function in very low birth weight infants. Biol Neonate 2006;89:274-80.
17. Seri I, Tulassay T, Kiszel J, et al. Effect of low dose dopamine infusion on prolactin and thyrotropin secretion in preterm infants with hyaline membrane disease. Biol Neonate 1985;47:317-22.
18. Van den Berghe G, de Zegher F, Lauwers P. Dopamine suppresses pituitary function in infants and children. Crit Care Med 1994;22:1747-53.
19. de Zegher F, Van den Berghe G, Devlieger H, et al. Dopamine inhibits growth hormone and prolactin secretion in the human newborn. Pediatr Res 1993;34:642-5.
20. Seri I, Somogyvari Z, Hovanyovszky S, et al. Developmental regulation of the inhibitory effect of dopamine on prolactin release in the preterm neonate. Biol Neonate 1998;73:137-44.
21. Lee E, Chen P, Rao H, et al. Effect of acute high dose dobutamine administration on serum thyrotrophin (TSH). Clin Endocrinol 1999;50:487-92.
22. Schilling T, Grundling M, Strang CM, et al. Effects of dopexamine, dobutamine or dopamine on prolactin and thyreotropin serum concentrations in high-risk surgical patients. Intensive Care Med 2004;30:1127-33.
23. Lucas A, Rennie J, Baker BA, et al. Low Plasma triiodothyronine concentrations and outcome in preterm infants. Arch Dis Child 1988;63:1201-6.
24. Lucas A, Baker BA, Cole TJ. Plasma prolactin and clinical outcome in preterm infants. Arch Dis Child 1990;65:977-83.
25. Torresani TE, Scherz R. Thyroid screening of neonates without use of radioactivity: evaluation of time-resolved nuoroimmunoassay of thyrotropin. Clin Chem 1986;32:1013-6.
26. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986;33:179-201.
27. Alderson P, Bunn F, Lefebvre C, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2004;4:CD001208.
28. Gill AB, Weindling AM. Echocardiography assessment of cardiac function in shocked very low birthweight infants. Arch Dis Child 1993;68:17-21.
29. Seri I. Cardiovascular, renal and endocrine actions of dopamine in neonates and children. J Pediatr 1995;126:333-44.
30. Stopfkuchen H, Queisser-Luft A, Vogel K. Cardiovasular responses to dobutamine determined by systolic time intervals in preterm infants. Crit Care Med 1990;18:722-4.
31. Bourchier D, Weston PJ. Randomised trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birthweight infants. Arch Dis Child 1997;76:F174-8.
32. Seri I, Tulassay T, Machay T, et al. Cardiovascular response to dopamine in hypotensive preterm neonates with severe hyaline membrane disease. Eur J Pediatr 1984;142:3-9.
33. Seri I, Rudas G, Bors Z, et al. Effects of low-dose dopamine infusion on cardiovascular and renal functions, cerebral blood flow, and plasma catecholamine levels in sick preterm neonates. Pediatr Res 1993;34:742-9.
34. Stopfkuchen H, Schranz D, Huth R, et al. Effects of dobutamine on left ventricular performance in newborns as determined by systolic time intervals. Eur J Pediatr 1987;146:135-9.
35. Wood DF, Johnston JM, Johnston DG. Dopamine, the dopamine D2 receptor and pituitary tumors. Clin Endocrinol 1991;35:455-66.
36. Frank JE, Faix JE, Hermos RJ, et al. Thyroid function in very low birth weight infants: effects on neonatal hypothyroidism screening. J Pediatr 1996;128:548-54.
37. Biswas S, Buffery J, Enoch H, et al. A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks' gestation during the first 2 weeks of life and their relationship to outcome. Pediatrics 2002;109:222-7.
38. Forster A, Magistretti P, Schorderet M. Effects of dobutamine on cyclic AMP acumulation induced by the stimulation of dopamine receptors in rabbit retina in vitro. Experimentia 1980;36:1108-10.
39. Ogilvy-Stuart AL, Hands SJ, Adcock CJ, et al. Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn. J Clin Endocrinol Metab 1998;83:3550-7.
40. Lewis DS, Jackson EM, Mott GE. Triiodothyronine accelerates maturation of bile acid metabolism in infant baboons. Am J Physiol 1995;2688:E889-96.
41. Redding RA, Douglas WHJ, Stein M. Thyroid hormone influence upon lung surfactant metabolism. Science 1972;175:994-6.
42. Leviton A, Paneth N, Reuss ML, et al. Hypothyroxinemia of prematurity and the risk of cerebral white matter damage. J Pediatr 1999;134:706-11.
43. Kok JH, Briet JM, van Wassenaer AG. Postnatal thyroid hormone replacement in very preterm infants. Semin Perinatol 2001;25:417- 25.
44. Devins SS, Miller A, Herndon BL, et al. Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit Care Med 1992;20:1644-9.